Eucrates Biomedical Acquisition (Eucrates Biomedical Acquisition) Short-Term Debt : $0.06 Mil (As of Dec. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Eucrates Biomedical Acquisition Short-Term Debt?

Eucrates Biomedical Acquisition's Short-Term Debt for the quarter that ended in Dec. 2022 was $0.06 Mil.

Eucrates Biomedical Acquisition's quarterly Short-Term Debt declined from Jun. 2022 ($0.19 Mil) to Sep. 2022 ($0.06 Mil) and declined from Sep. 2022 ($0.06 Mil) to Dec. 2022 ($0.06 Mil).

Eucrates Biomedical Acquisition's annual Short-Term Debt stayed the same from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($0.00 Mil) but then increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.06 Mil).

Eucrates Biomedical Acquisition Short-Term Debt Historical Data

The historical data trend for Eucrates Biomedical Acquisition's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eucrates Biomedical Acquisition Short-Term Debt Chart

Eucrates Biomedical Acquisition Annual Data

Trend

Dec20

Dec21

Dec22

Short-Term Debt

0.06

Eucrates Biomedical Acquisition Quarterly Data
	Aug20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Short-Term Debt	Get a 7-Day Free Trial					-	0.19	0.19	0.06	0.06

Eucrates Biomedical Acquisition Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Eucrates Biomedical Acquisition Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Eucrates Biomedical Acquisition's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Eucrates Biomedical Acquisition (Eucrates Biomedical Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Eucrates Biomedical Acquisition Corp (NAS:EUCRW) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

250 West 55th Street, Suite 13D, New York, NY, USA, 10019

Website

Eucrates Biomedical Acquisition Corp is a blank check company.

Eucrates Biomedical Acquisition (Eucrates Biomedical Acquisition) Headlines

From GuruFocus

Eucrates Biomedical Acquisition Corp. Announces Liquidation

By PRNewswire PRNewswire • 04-11-2023

Eucrates Biomedical Acquisition Corp. Receives Expected Notice From Nasdaq Regarding Delayed Quarterly Report

By PRNewswire PRNewswire • 06-01-2021

Eucrates Biomedical Acquisition Corp. Announces Closing Of $100 Million Initial Public Offering

By PRNewswire PRNewswire • 10-28-2020